Sign In

Credits Offered

  • Continuing Medical Education (CME): 12.25 AMA PRA Category 1 Credits
  • Continuing Education (CE): 12.25 Contact Hours
  • Pharmacology Education: 2.0 Pharmacology Credits

Accreditation and Designation Statements

Continuing Medical Education (CME)

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education (CE)

Amedco is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This course is co-provided by Amedco and the American Association for the Study of Liver Diseases (AASLD) with a maximum of 12.25 contact hours. In addition to continuing nursing education, the following presentations are also eligible for 2.0 pharmacotherapeutic hours:

  • Advances in the Management of Ascites and Variceal Hemorrhage - .25 hour
  • Current and Evolving Treatments for Alcoholic Hepatitis - .25 hour
  • What Can I Treat My NASH Patients With? - .25 hour
  • Emerging Treatments for Cholestatic Liver Diseases - .25 hour
  • Post-Transplant Care of the Recipient: The role of the Community Gastroenterologist/Hepatologist - .25 hour
  • What Do We Do with the HCV Non-Responder - .25 hour
  • Treatment of HCV in Decompensated Cirrhosis: Treat Pre or Post-Transplant - .25 hour
  • HBV Therapy: Do We Ever Stop therapy and When? - .25 hour

Maintenance of Certification (MOC) 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Monday, July 17, 2017. A link to the CME evaluation will be emailed to attendees after the meeting.

CE Credits
Satisfactory completion

Participants must complete an evaluation form to receive a certificate of completion by Monday, July 17, 2017. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. A link to the CE evaluation will be emailed to attendees after the meeting.

MOC Points

Physicians seeking ABIM MOC points must complete the CME evaluation and the MOC evaluation by Monday, July 17, 2017. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation that will be emailed to all attendees, and will remain live until Monday, July 17, 2017.

MOC points will be reported to the ABIM and ABP by Thursday, July 20, 2017 for attendees who successfully complete the MOC evaluation.

Needs Statement

The 2017 Clinical Hepatology Course is a prime opportunity for hepatology professionals to stay updated on the state-of-the-art management of liver disease. Presentations will offer clinically relevant insights on many aspects in patient care in liver disease, and a chance to discuss controversies commonly seen in clinical practice with key leaders in the field.

This 1 1/2 day course will offer didactic lectures in 6 topic areas relevant to mid-level hepatology professionals. A breakout session titled Preventative Health Strategies in the Outpatient Management of Cirrhosis will feature a small, interactive discussion with session organizers and networking opportunities with other attendees.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Discuss controversies in disease diagnosis and/or management in patients with a broad range of liver disease.
  • Assess and implement new mechanistic insights and treatment tools with broad application to patients with liver disease.
  • Apply new skills to patient care learned through direct interaction with faculty from case-based discussion.

Target Audience

  • Clinical researchers in the field of liver disease
  • Fellows/Trainees
  • Gastroenterologists
  • Hepatologists
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Primary Care MDs
  • Surgeons
  • Nurses

This activity was planned in the context of the following ACGMD/IOM/IPEC competencies: Patient-centered Care, Work in Interdisciplinary Teams, Quality Improvement, Practice Based Learning and Improvement, Cognitive Expertise, Patient Care, and Medical Knowledge.

Acknowledgement of Financial or Other Support

Any support by grants for this activity will be disclosed in the program syllabus.